Logo 1 Logo 2

Clinical Trial Details

Trial ID: L3601
Source ID: NCT00097084
Associated Drug: Insulin Detemir
Title: Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes|Diabetes Mellitus, Type 2
Interventions: DRUG: insulin detemir|DRUG: insulin glargine|DRUG: insulin aspart
Outcome Measures: Primary: HbA1c, after 1 year trial period | Secondary: Adverse events|Body weight|Hypoglycemia|Blood glucose|Insulin Treatment Satisfaction
Sponsor/Collaborators: Sponsor: Novo Nordisk A/S
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 324
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2004-09
Completion Date: 2005-12
Results First Posted:
Last Update Posted: 2017-01-27
Locations: Novo Nordisk Investigational Site, Little Rock, Arkansas, 72204, United States|Novo Nordisk Investigational Site, Inglewood, California, 90301, United States|Novo Nordisk Investigational Site, San Francisco, California, 94143-0780, United States|Novo Nordisk Investigational Site, Santa Ana, California, 92705, United States|Novo Nordisk Investigational Site, Spring Valley, California, 91978, United States|Novo Nordisk Investigational Site, Boca Raton, Florida, 33433, United States|Novo Nordisk Investigational Site, Jacksonville, Florida, 32216, United States|Novo Nordisk Investigational Site, Lake Mary, Florida, 32746, United States|Novo Nordisk Investigational Site, Melbourne, Florida, 32901, United States|Novo Nordisk Investigational Site, Orlando, Florida, 32804, United States|Novo Nordisk Investigational Site, Palm Harbor, Florida, 34684, United States|Novo Nordisk Investigational Site, Vero Beach, Florida, 32960, United States|Novo Nordisk Investigational Site, Athens, Georgia, 30606, United States|Novo Nordisk Investigational Site, Idaho Falls, Idaho, 83404-7596, United States|Novo Nordisk Investigational Site, Topeka, Kansas, 66606, United States|Novo Nordisk Investigational Site, Omaha, Nebraska, 68114, United States|Novo Nordisk Investigational Site, Las Vegas, Nevada, 89119-6100, United States|Novo Nordisk Investigational Site, Berlin, New Jersey, 08009, United States|Novo Nordisk Investigational Site, Asheville, North Carolina, 28803, United States|Novo Nordisk Investigational Site, Hermitage, Pennsylvania, 16148, United States|Novo Nordisk Investigational Site, Philadelphia, Pennsylvania, 19107, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75235, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75246, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75390-8858, United States|Novo Nordisk Investigational Site, San Antonio, Texas, 78229, United States|Novo Nordisk Investigational Site, Newport News, Virginia, 23606, United States|Novo Nordisk Investigational Site, Richmond, Virginia, 23249, United States|Novo Nordisk Investigational Site, Tacoma, Washington, 98405, United States|Novo Nordisk Investigational Site, Espoo, 02740, Finland|Novo Nordisk Investigational Site, Helsinki, 00260, Finland|Novo Nordisk Investigational Site, Kurikka, FI-61300, Finland|Novo Nordisk Investigational Site, Lahti, FI-15110, Finland|Novo Nordisk Investigational Site, Lapua, FI-62100, Finland|Novo Nordisk Investigational Site, Oulu, FI-90220, Finland|Novo Nordisk Investigational Site, Turku, 20700, Finland|Novo Nordisk Investigational Site, Brest, 29200, France|Novo Nordisk Investigational Site, Le Mans, France|Novo Nordisk Investigational Site, MONTPELLIER cedex 5, 34295, France|Novo Nordisk Investigational Site, Nanterre, 92014, France|Novo Nordisk Investigational Site, Narbonne, 11108, France|Novo Nordisk Investigational Site, NEVERS cedex, 58033, France|Novo Nordisk Investigational Site, Orleans, France|Novo Nordisk Investigational Site, Paris, 75181, France|Novo Nordisk Investigational Site, Venissieux, 69200, France|Novo Nordisk Investigational Site, Bergen, NO-5009, Norway|Novo Nordisk Investigational Site, Notodden, NO-3675, Norway|Novo Nordisk Investigational Site, Sarpsborg, 1723, Norway|Novo Nordisk Investigational Site, Ski, NO-1400, Norway|Novo Nordisk Investigational Site, Stavanger, 4011, Norway|Novo Nordisk Investigational Site, Trondheim, NO-7030, Norway|Novo Nordisk Investigational Site, Falun, 791 82, Sweden|Novo Nordisk Investigational Site, Göteborg, 417 17, Sweden|Novo Nordisk Investigational Site, Kalmar, 391 85, Sweden|Novo Nordisk Investigational Site, Lund, 221 85, Sweden|Novo Nordisk Investigational Site, Lund, 223 70, Sweden|Novo Nordisk Investigational Site, Malmö, 214 26, Sweden|Novo Nordisk Investigational Site, Motala, 591 85, Sweden|Novo Nordisk Investigational Site, Oskarshamn, 572 28, Sweden|Novo Nordisk Investigational Site, Uddevalla, 451 50, Sweden|Novo Nordisk Investigational Site, Ängelholm, 262 91, Sweden
URL: https://clinicaltrials.gov/show/NCT00097084

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress